ID: ALA3274979

Max Phase: Preclinical

Molecular Formula: C13H17NO

Molecular Weight: 203.28

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)N1c2ccccc2C(C)(C)C1C

Standard InChI:  InChI=1S/C13H17NO/c1-9-13(3,4)11-7-5-6-8-12(11)14(9)10(2)15/h5-9H,1-4H3

Standard InChI Key:  DADJYPOXGKFWGX-UHFFFAOYSA-N

Associated Targets(non-human)

Glycine receptor subunit alpha-1 65 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 203.28Molecular Weight (Monoisotopic): 203.1310AlogP: 2.72#Rotatable Bonds: 0
Polar Surface Area: 20.31Molecular Species: NEUTRALHBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.27CX LogD: 2.27
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.63Np Likeness Score: 0.38

References

1. Hershenson FM, Prodan KA, Kochman RL, Bloss JL, Mackerer CR..  (1977)  Synthesis of beta-spiro[pyrrolidinoindolines], their binding to the glycine receptor, and in vivo biological acitivity.,  20  (11): [PMID:199727] [10.1021/jm00221a016]

Source